About HESA
The Hashimoto’s Encephalopathy SREAT Alliance (“HESA”) is a 501(c)(3) nonprofit organization formed in 2012. HESA’s purpose is collect, archive, and share information regarding Hashimoto’s Encephalopathy (“HE”), also known as Steroid Responsive Encephalopathy Associated with Thyroiditis (“SREAT”), or simply autoimmune encephalopathy (“AE”), with the public and medical professionals.

“The Hashimoto’s Encephalopathy SREAT Alliance is a 501(c)(3) nonprofit organization formed in 2012.”
Other names used to describe HE/SREAT are nonvasculitic autoimmune meningoencephalitis (“NAIM”), and encephalopathy associated with autoimmune thyroid disease
(“EAATD”).
HESA takes no position on the most appropriate name for the disease, however on this website the abbreviation “HE” is used as a shorthand way to refer to the condition.
The purpose of HESA is to educate the public and medical professionals concerning Hashimoto’s encephalopathy, and the need for increased funding for the detection, treatment, and ultimate cure of the disease.
HESA coordinates with other nonprofit organizations around the world, including E-Global, the Autoimmune Encephalitis Alliance, and the Encephalitis Society, to share scientific information, administer and contribute to online support communities for patients and their loved ones, provide speakers for relevant conferences and seminars, and generate funding for research. We appreciate your tax-deductible donations which further this vital work.
Disclaimer:
This website is not a substitute for professional advice, and the content here is not intended for use in diagnosing, curing, or preventing disease. The site does not employ and is not overseen by medical professionals. Articles and studies listed here are intended solely for personal use and reference.
Although you will find a great deal of information about HE/SREAT on this website, HESA cannot provide medical advice. If you have HE/SREAT, or think you may have it, consult a qualified neurologist, preferably one with experience addressing immune-mediated illness.
HESA shall not be held responsible for the contents of links to studies, their errors, omissions, or any malicious software they may contain.